ReachBio Research Labs Offers New Services for ADC Off-target Toxicity and Linker Stability Read more
CytomX Therapeutics Announces Second Target Selection and Program Initiation with AbbVie Under Ongoing Read more
Extensive expansion at Lonza’s Tampa site provides streamlined services for solid oral dosage forms Read more
NeuroRx Initiates Pivotal Study for NRX-101, a Breakthrough Designation Therapy Targeting Suicidal Bipolar Depression Read more
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio Read more
Mirati Announces Clinical Collaboration to Evaluate MRTX849 in Combination with SHP2 Inhibitor TNO155 Read more
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics Read more
Under the spotlight: Amgen’s VP for the Center of Observational Research Will Discuss the Role of RWE in a Comprehensive Product Evidence Generation Plan Read more